A Sustained‐Release Depot of Thermosensitive Polypeptide Fused Glycosidase Synergizes with Vancomycin to Eradicate Implant Infections
Small · 2026-05 · 22 (29)
DOI: 10.1002/smll.202514217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 31.03.2026. Verfasst von Hao Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Glycoside Hydrolases, Vancomycin, Peptides, Temperature. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Biomedical implants have revolutionized medicine, but they increase the risk of infection. The treatment of implant infection is tricky because bacterial biofilms performed on the implants are difficult to remove, and bacteria in the biofilm have high resistance and tolerance to antibiotics. Herein, we report a sustained release depot of a thermosensitive glycoside hydrolase of ELP‐DspB, in which dispersin B (DspB) is genetically fused to a thermosensitive elastin‐like polypeptide (ELP), to efficiently degrade bacterial biofilms and thus overcome antibiotic resistance. ELP‐DspB possesses the antibiofilm bioactivity of DspB to synergize with antibiotics as well as the thermosensitivity of ELP. Moreover, it not only improves the stability of DspB but also diminishes the immunogenicity of DspB. In a mouse model of implant infection by methicillin resistant Staphylococcus epidermidis (MRSE), the thermosensitivity of ELP‐DspB enabled the formation of a one‐month sustained‐release drug reservoir upon topical administration near the MRSE biofilm‐infected implant. In combination with antibiotics, a single subcutaneous injection of ELP‐DspB efficiently eradicated implant infections without detectable side effects, which was not achieved by DspB. Generally, the ELP fusion is a promising strategy to improve the efficacy of glycoside hydrolases in synergy with antibiotics in eradicating biofilm‐related implant infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Peking University First Hospital, Beijing, China.
- Department of Biomedical Engineering, Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
- Peking University-Yunnan Baiyao International Medical Research Center, Beijing, China.
- Peking University International Cancer Institute, Beijing, China.
- State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.
- Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, Peking University, Beijing, China.
ORCID-Profile: Weiping Gao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, H., Fan, G., Gong, Y., Wang, H., Wang, X., Juma, T., Zhang, F., Sun, Y., Gong, L., Meng, Z., Liu, H., Pan, L., Liang, G., Wang, L., Lu, F., Cao, Y., & Gao, W. (2026). A Sustained‐Release Depot of Thermosensitive Polypeptide Fused Glycosidase Synergizes with Vancomycin to Eradicate Implant Infections. Small, 22(29). https://doi.org/10.1002/smll.202514217
Vancouver
Wang H, Fan G, Gong Y, Wang H, Wang X, Juma T, et al. A Sustained‐Release Depot of Thermosensitive Polypeptide Fused Glycosidase Synergizes with Vancomycin to Eradicate Implant Infections. Small. 2026;22(29). doi:10.1002/smll.202514217
BibTeX
@article{Wang2026,
author = {Wang, Hao and Fan, Guoqing and Gong, Yuxin and Wang, Hongbin and Wang, Xuan and Juma, Talante and Zhang, Fan and Sun, Yuanzi and Gong, Like and Meng, Zhichao and Liu, Heng and Pan, Liping and Liang, Guanghua and Wang, Lin and Lu, Fengmin and Cao, Yongping and Gao, Weiping},
title = {A Sustained‐Release Depot of Thermosensitive Polypeptide Fused Glycosidase Synergizes with Vancomycin to Eradicate Implant Infections},
journal = {Small},
year = {2026},
volume = {22},
number = {29},
doi = {10.1002/smll.202514217}
}
EUVIMED